• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theralase Technologies Inc (OP:TLTFF)

0.1430 UNCHANGED
Streaming Delayed Price Updated: 12:04 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theralase Technologies Inc

< Previous 1 2 3 Next >
Theralase(R) Announces Brokered LIFE Financing
October 23, 2023
Via ACCESSWIRE
Theralase(R) Optimizes Phase II Bladder Cancer Clinical Study
October 23, 2023
Via ACCESSWIRE
Theralase(R) Provides Update on Bladder Cancer Clinical Study
October 16, 2023
Via ACCESSWIRE
Theralase(R) Files US Patent for Enhanced Immunotherapy
October 05, 2023
Via ACCESSWIRE
Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
September 29, 2023
Via ACCESSWIRE
Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
September 27, 2023
Via ACCESSWIRE
Theralase(R) Grants Stock Options
September 21, 2023
Via ACCESSWIRE
Theralase(R) Closes Private Placement Equity Financing
September 07, 2023
Via ACCESSWIRE
Theralase Release’s 2Q2023 Interim Financial Statements
August 29, 2023
Via ACCESSWIRE
Theralase(R) Closes Non-Brokered Private Placement Equity Financing
June 30, 2023
Via ACCESSWIRE
Theralase(R) Announces Appointment of New Independent Director
June 06, 2023
Via ACCESSWIRE
Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
May 30, 2023
Via ACCESSWIRE
Theralase(R) Releases 1Q2023 Interim Financial Statements
May 30, 2023
Via ACCESSWIRE
Theralase(R) Appoints Roger DuMoulin-White as President and Chief Executive Officer
May 24, 2023
Via ACCESSWIRE
Theralase Provides Update on Phase II Bladder Cancer Study
May 10, 2023
Via ACCESSWIRE
Theralase Release FY2020 Audited Financial Statements
April 28, 2021
TORONTO, ON / ACCESSWIRE / April 28, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and... 
From Theralase Technologies Inc.
Via AccessWire
Theralase(R) Releases Quarterly Newsletter
April 27, 2021
TORONTO, ON / ACCESSWIRE / April 27, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and... 
From Theralase Technologies Inc.
Via AccessWire
Theralase Commences Collaborative Research with National Microbiology Laboratory for Development of Coronavirus Vaccine
April 09, 2021
TORONTO, ON / ACCESSWIRE / April 9, 2021 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and... 
From Theralase Technologies Inc.
Via AccessWire
< Previous 1 2 3 Next >
Recent Quotes
View More
Symbol Price Change (%)
GOOG  243.05
+5.56 (2.34%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap